Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 37307 - brain electrical stimulation system, antitremor - leads are designed for introduction into the brain using standard stereotactic neurosurgical techniques & feature electrodes on a stiff distal end with an inactive lead tip. the proximal end contains contact bands that correspond with each of the distal electrodes & an inactive band that functions as a contact for a set screw when connecting to a compatible extension. the leads contain segmented electrodes that can be activated independently to focus stimulation in one direction. st. jude medical deep brain stimulation leads are intended to deliver stimulation to target areas in the brain. the device is mr conditional.

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - tablet - 2.5 mg - amlodipine is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. amlodipine is indicated for the symptomatic treatment of chronic stable angina. amlodipine may be used alone or in combination with other antianginal agents. amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. amlodipine may be used as monotherapy or in combination with other antianginal drugs. in patients with recently documented cad by angiography and without heart failure or an ejection fraction <40%, amlodipine besylate tablets are indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure. amlodipine is contraindicated in patients with known sensitivity to amlodipine.

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories ltd. - isosorbide dinitrate (unii: ia7306519n) (isosorbide - unii:wxr179l51s) - isosorbide dinitrate 40 mg - isosorbide dinitrate extended-release tablets are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of controlled- release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. allergic reactions to organic nitrates are extremely rare, but they do occur. isosorbide dinitrate extended-release tablets are contraindicated in patients who are allergic to isosorbide dinitrate or to any of its other ingredients.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 200mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - paracetamol - suppository - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 60mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 30mg/1ml

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - nimodipine (unii: 57wa9qz5wh) (nimodipine - unii:57wa9qz5wh) - nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., hunt and hess grades i-v). the concomitant use of nimodipine with strong inhibitors of cyp3a4 such as some macrolide antibiotics (e.g., clarithromycin, telithromycin), some anti-hiv protease inhibitors (e.g., delaviridine, indinavir, nelfinavir, ritonavir, saquinavir), some azole antimycotics (e.g., ketoconazole, itraconazole, voriconazole) and some antidepressants (e.g., nefazadone) is contraindicated because of a risk of significant hypotension (see precautions, drug interactions ). there have been no reported instances of drug abuse or dependence with nimodipine.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

averroes pharmaceuticals sdn. bhd. - ondansetron hydrochloride dihydrate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

averroes pharmaceuticals sdn. bhd. - ondansetron hydrochloride dihydrate -